Multi-center, open-labed, prospective study of cilostazol (Pletaal) Effect on uncontrolled Variant angina

Trial Profile

Multi-center, open-labed, prospective study of cilostazol (Pletaal) Effect on uncontrolled Variant angina

Recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Cilostazol (Primary)
  • Indications Embolism and thrombosis; Variant angina pectoris
  • Focus Therapeutic Use
  • Acronyms PEVA
  • Most Recent Events

    • 13 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top